SCYNEXIS, Inc. (SCYX) is a publicly traded Healthcare sector company. As of September 10, 2026, SCYX trades at $4.91 with a market cap of $51.24M and a P/E ratio of -3.41. SCYX moved -2.33% today. Year to date, SCYX is -2.95%; over the trailing twelve months it is -35.95%. Its 52-week range spans $3.53 to $10.48. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces SCYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SCYNEXIS, Inc. (SCYX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SCYX moved -2.33% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.91 |
| Market Cap | $51.24M |
| P/E Ratio | -3.41 |
| EPS | $-1.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.48 |
| 52-Week Low | $3.53 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $19.21M |
| Net Income | $-10.23M |
| Gross Margin | 0.00% |
2 analysts cover SCYX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.